The quick answer
Exercise is the foundation. Injections are possible additions, not replacements.
Current NICE guidance recommends tailored therapeutic exercise as a core treatment for osteoarthritis. A corticosteroid injection can be considered for short-term relief—usually 2 to 10 weeks—when other medicines are unsuitable or ineffective, or when pain is preventing exercise. NICE recommends that hyaluronic acid injections should not be offered routinely because the average benefit is small and uncertain.
At a glance
How the three options compare
| Option | Main role | Expected timescale | NICE position |
|---|---|---|---|
| Tailored exercise | Improve strength, confidence and day-to-day function | Built over weeks and continued longer term | Core treatment |
| Steroid injection | Temporary symptom relief, sometimes to support exercise | Short term; NICE says around 2–10 weeks | Consider selectively |
| Hyaluronic acid | Aims to reduce pain; response is unpredictable | If it helps, benefit may take time to emerge | Do not offer routinely |
Averages from research cannot predict exactly how one person will respond. Your diagnosis, health, previous treatment and goals still matter.
First, a useful distinction
Treat the person, not only the scan
Knee osteoarthritis describes changes within a joint, but an X-ray does not tell the whole story. Pain, stiffness, strength, sleep, confidence, work demands and other health conditions can all affect what you can do. Two people with similar X-rays may need very different plans.
A good assessment checks whether osteoarthritis is the most likely source of symptoms, identifies what is limiting you and looks for signs that a different investigation or referral is needed. You can read more about our knee osteoarthritis assessment and treatment in Hull.
Option 1
Exercise: the starting point for most people
NICE recommends therapeutic exercise tailored to the individual. That might include strengthening the muscles around the knee and hip, aerobic activity, balance work and gradual practice of the tasks you want to regain.
Exercise is not a quick repair and it does not regrow cartilage. Its value is in improving the knee's capacity, your confidence in using it and your overall health. A short-lived increase in discomfort can happen when activity is progressed; the dose should be adjusted rather than abandoned automatically.
Research finds that average improvements in pain can be modest and individual response varies. This is why a useful programme is specific, progressive and connected to a meaningful goal—not simply a generic sheet of exercises. Private physiotherapy at Resolve begins with that individual assessment.
For a practical starting point, see our illustrated guide to three knee osteoarthritis exercises, including technique, repetitions and ways to adjust the movements.
You want to improve walking, stairs, work, sport or confidence over the longer term and can follow a plan that is adjusted as you progress.
Option 2
Steroid injection: short-term relief for a specific purpose
A corticosteroid injection places anti-inflammatory medicine into the knee joint. NICE says it may be considered when other medicines are ineffective or unsuitable, or when short-term relief could help someone take part in therapeutic exercise.
The key phrase is short term. NICE advises explaining that benefit usually lasts around 2 to 10 weeks. Relief is not guaranteed, and an injection does not reverse osteoarthritis. It works best when there is a clear reason for using that temporary window—for example, settling a difficult flare so rehabilitation can restart.
Screening matters. Diabetes, blood-thinning medicines, infection risk, recent or planned surgery and previous injections can change the decision. Repeated injections also deserve careful review rather than becoming an automatic routine. Learn what is covered in a steroid injection consultation in Hull.
There is a defined short-term goal, the likely benefits outweigh the risks and the relief will support a broader management plan.
Option 3
Hyaluronic acid: uncertain benefit and a clear NICE caution
Hyaluronic acid—sometimes called viscosupplementation—is injected into the knee with the aim of improving joint lubrication and reducing symptoms. It does not regrow cartilage or cure osteoarthritis.
Studies have produced mixed results. A large 2022 review found that the average pain reduction compared with placebo was small and below the threshold usually considered clinically important. NICE therefore recommends that intra-articular hyaluronan should not be offered for osteoarthritis.
Resolve will explain that recommendation plainly. A hyaluronic acid consultation is not a promise that an injection is right for you: it is a chance to discuss the uncertain benefit, cost, risks and alternatives before making an informed decision.
Be cautious of claims that hyaluronic acid “rebuilds”, “restores” or “regenerates” knee cartilage. Current clinical evidence does not support those promises.
Shared decision-making
How should you choose?
The sensible question is not “Which treatment is best?” in isolation. It is “What problem are we trying to solve, and what option gives me a worthwhile balance of benefit, risk, cost and effort?”
- 01Confirm the working diagnosis.
Check whether knee osteoarthritis fits the pattern and whether anything needs investigation or referral.
- 02Define the goal.
Short-term pain relief and lasting improvement in function are different objectives.
- 03Review what you have tried.
The detail, dosage and duration of previous exercise or medication matter more than a simple “it did not work”.
- 04Weigh risks and practicalities.
Your health, preferences, treatment cost and tolerance of uncertainty should be part of the decision.
If pain, stiffness or loss of function is substantially affecting quality of life despite suitable non-surgical care, a referral to discuss joint replacement may be appropriate. An injection should not delay that conversation without a good reason.
The Resolve approach
Assessment first. No pressure to choose a procedure.
At Resolve MSK Clinic in Hull, the first job is to understand your symptoms and priorities. If an injection is being considered, we discuss realistic benefit, alternatives, relevant guidance and risk before anything is agreed. Sometimes the right outcome is rehabilitation, a medication discussion with your GP, further investigation or referral—not an injection.
Joint and soft-tissue injection consultations in HullIf rehabilitation is the more appropriate next step, see how private physiotherapy in Hull is tailored to your symptoms, function and goals.
Common questions
Knee osteoarthritis treatment FAQs
What is usually the first treatment for knee osteoarthritis?+
NICE recommends tailored therapeutic exercise as a core treatment, alongside information and support with weight management when appropriate. The plan should match your ability, symptoms and goals.
How long can a steroid injection help knee osteoarthritis?+
NICE advises that any benefit is short term—typically 2 to 10 weeks. Some people notice useful relief and others do not. An injection may be considered when other medicines are unsuitable or ineffective, or to make therapeutic exercise more manageable.
Does hyaluronic acid rebuild cartilage?+
There is no good evidence that a hyaluronic acid injection regrows lost knee cartilage. It is intended to change symptoms, not reverse osteoarthritis, and any benefit is uncertain.
Does Resolve MSK offer an injection without an assessment?+
No. An assessment and appropriate screening come first. Expected benefits, risks, alternatives and the NICE position are discussed before any procedure is agreed.
Evidence used
Sources and further reading
- NICE NG226: Osteoarthritis in over 16s—recommendations
- BMJ: Viscosupplementation for knee osteoarthritis, systematic review and meta-analysis (2022)
- Corticosteroid injections for knee osteoarthritis, systematic review and meta-analysis (2024)
- Exercise therapy for knee osteoarthritis, systematic review of reviews (2026)
Published 26 August 2026 and last clinically reviewed 20 September 2026. This page will be reviewed when material guidance changes, or by August 2027.
